Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.

Ballana E, Riveira-Munoz E, Pou C, Bach V, Parera M, Noguera M, Santos JR, Badia R, Casadellà M, Clotet B, Paredes R, Martínez MA, Brander C, Esté JA.

Immunobiology. 2013 Apr;218(4):543-7. doi: 10.1016/j.imbio.2012.06.012. Epub 2012 Jun 28.

PMID:
22818666
2.

Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.

Reiche EM, Ehara Watanabe MA, Bonametti AM, Morimoto HK, Akira Morimoto A, Wiechmann SL, Matsuo T, Carvalho De Oliveira J, Vissoci Reiche F.

Int J Mol Med. 2008 Nov;22(5):669-75.

PMID:
18949389
3.

Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.

Goh WC, Markee J, Akridge RE, Meldorf M, Musey L, Karchmer T, Krone M, Collier A, Corey L, Emerman M, McElrath MJ.

J Infect Dis. 1999 Mar;179(3):548-57.

PMID:
9952360
4.

Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.

Teixeira SL, Bastos FI, Hacker MA, Morgado MG.

Infect Genet Evol. 2009 Jul;9(4):638-42. doi: 10.1016/j.meegid.2009.03.007. Epub 2009 Apr 5.

PMID:
19460331
5.

Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.

Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS; International Meta-Analysis of HIV Host Genetics.

AIDS. 2003 Feb 14;17(3):377-87.

PMID:
12556692
6.

Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.

van Rij RP, Portegies P, Hallaby T, Lange JM, Visser J, de Roda Husman AM, van 't Wout AB, Schuitemaker H.

J Infect Dis. 1999 Sep;180(3):854-7.

PMID:
10438379
7.

Low-cost simultaneous detection of CCR5-delta32 and HLA-B*5701 alleles in human immunodeficiency virus type 1 infected patients by selective multiplex endpoint PCR.

Rosi A, Meini G, Materazzi A, Vicenti I, Saladini F, Zazzi M.

J Virol Methods. 2015 Nov;224:102-4. doi: 10.1016/j.jviromet.2015.08.020. Epub 2015 Sep 2.

PMID:
26341061
8.

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR; International Meta-Analysis of HIV Host Genetics.

Ann Intern Med. 2001 Nov 6;135(9):782-95.

PMID:
11694103
9.

Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.

Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, Uglialoro AM, Clavijo OP, Rosenberg ES, Kalams SA, Braun JD, Boswell SL, Walker BD, Goldfeld AE.

Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5140-5. Epub 2001 Apr 17.

10.

Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.

Salem AH, Batzer MA.

Mutat Res. 2007 Mar 1;616(1-2):175-80. Epub 2006 Dec 12.

PMID:
17166523
11.

CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.

Duarte RF, Salgado M, Sánchez-Ortega I, Arnan M, Canals C, Domingo-Domenech E, Fernández-de-Sevilla A, González-Barca E, Morón-López S, Nogues N, Patiño B, Puertas MC, Clotet B, Petz LD, Querol S, Martinez-Picado J.

Lancet HIV. 2015 Jun;2(6):e236-42. doi: 10.1016/S2352-3018(15)00083-1. Epub 2015 May 19.

PMID:
26423196
12.

Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.

Takácová M, Nogová P, Hábeková M, Staneková D.

Acta Virol. 2008;52(4):261-4.

PMID:
19143484
13.

Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection.

Romiti ML, Colognesi C, Cancrini C, Mas A, Berrino M, Salvatori F, Orlandi P, Jansson M, Palomba E, Plebani A, Bertran JM, Hernandez M, de Martino M, Amoroso A, Tovo PA, Rossi P, Espanol T, Scarlatti G.

Mol Med. 2000 Jan;6(1):28-36.

14.

Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.

Zwolińska K, Knysz B, Rybka K, Pazgan-Simon M, Gąsiorowski J, Sobczyński M, Gładysz A, Piasecki E.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):54-60. doi: 10.1089/AID.2011.0362. Epub 2012 Oct 9.

PMID:
22957692
15.

New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS.

Hendel H, Caillat-Zucman S, Lebuanec H, Carrington M, O'Brien S, Andrieu JM, Schächter F, Zagury D, Rappaport J, Winkler C, Nelson GW, Zagury JF.

J Immunol. 1999 Jun 1;162(11):6942-6.

16.

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.

Laurichesse JJ, Persoz A, Theodorou I, Rouzioux C, Delfraissy JF, Meyer L.

HIV Med. 2007 May;8(4):213-9.

17.

Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.

Ioannidis JP, Contopoulos-Ioannidis DG, Rosenberg PS, Goedert JJ, De Rossi A, Espanol T, Frenkel L, Mayaux MJ, Newell ML, Pahwa SG, Rousseau C, Scarlatti G, Sei S, Sen L, O'Brien TR; HIV Host Genetics International Meta-Analysis Group.

AIDS. 2003 Jul 25;17(11):1631-8.

PMID:
12853745
18.

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, Offergeld R, Sauerbruch T, Spengler U.

Gastroenterology. 2002 Jun;122(7):1721-8.

PMID:
12055576
19.

Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32.

Michael NL, Nelson JA, KewalRamani VN, Chang G, O'Brien SJ, Mascola JR, Volsky B, Louder M, White GC 2nd, Littman DR, Swanstrom R, O'Brien TR.

J Virol. 1998 Jul;72(7):6040-7.

20.

Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.

Apostolakis S, Baritaki S, Krambovitis E, Spandidos DA.

J Clin Virol. 2005 Dec;34(4):310-4.

PMID:
16286055

Supplemental Content

Support Center